British pharmaceuticals giant AstraZeneca said Thursday that its COVID jab generated $1.2 billion (1.0 billion euros) in sales in the first half of the year as global vaccination programmes accelerated.
Jul 29, 2021
0
123
The amount of charity care provided by government and nonprofit hospitals falls short of the obligation implied by their favorable tax treatment, according to a new study published in the April issue of Health Affairs by ...
Apr 8, 2021
0
3
New Yorkers can now possess up to 3 ounces of cannabis under a legalization bill signed Wednesday by Gov. Andrew Cuomo, while sales of recreational-use marijuana won't become legal for an estimated 18 months until the state ...
Mar 31, 2021
0
0
(HealthDay)—Faces masks, hand sanitizer, and disinfecting wipes are among the types of COVID-19 personal protective equipment (PPE) that Americans can deduct as a medical expense when filing taxes this year, the Internal ...
Mar 30, 2021
0
7
Pfizer, the first company to get U.S. emergency use authorization for a COVID-19 vaccine, swung to a small profit in the fourth-quarter as it started shipping vaccines globally.
Feb 2, 2021
0
0
Dr. Ira Weintraub, a recently retired orthopedic surgeon who now works at a medical billing consultancy, saw a hip replacement bill for over $400,000 earlier this year.
Aug 13, 2020
1
3
Scientists have long been concerned that the common practice of medical journals accepting commercial payments from pharmaceutical companies may lead to pro-industry bias in published articles. According to new research at ...
Jul 27, 2020
0
3
Most states that transition to block grant funding for Medicaid—in which the federal government provides a fixed annual sum—would see lower revenue for their community health centers that care for Medicaid beneficiaries ...
Oct 17, 2019
0
0
Industry has unduly influenced the regulations for TV advertising of unhealthy foods to children, likely weakening legislation in this area, argue doctors in an analysis, published in the online journal BMJ Open.
Sep 23, 2019
0
1
Eli Lilly raised its 2019 forecast after a jump in sales from the diabetes treatment Trulicity helped push the drugmaker to a better-than-expected second quarter.
Jul 30, 2019
0
0
